Febbie Phiri
Family · San Antonio, TXNPI 1437818101
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 991 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $11,489, 2.5 times the $4,520 reported in 2022. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 991 payments — averaging $31.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Novo Nordisk$3K
- Abbott$2K
- Dexcom, Inc.$2K
- Lilly USA, LLC$2K
- Mannkind Corporation$1K
- plus $14K from 37 others
What the payments were for
- Travel & lodging$1,2744%
- Food & beverage$29,64796%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$2,258
- FREESTYLE LIBRE 3$1,730
- DEXCOM G6 TRANSMITTER$1,216
- iLet Bionic Pancreas$923
- Korlym$697
- CeQur Simplicity$651
- TWIIST$549
- INPEN SMART INSULIN DELIVERY SYSTEM$519
- FARXIGA$485
- Ozempic$477
- RECORLEV$371
- Omnipod$275
- TEPEZZA$273
- Wegovy$268
- REZDIFFRA$254
- ZEPBOUND$250
- MINIMED 770G$250
- MOUNJARO$242
- t:slim X2 Insulin Pump with Control-IQ$240
- Tymlos$203
How this compares
$30,921 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 429 | $611,628 |
| MounjaroTirzepatide | 364 | $540,056 |
| KorlymMifepristone | 12 | $484,079 |
| JardianceEmpagliflozin | 191 | $276,223 |
| TrulicityDulaglutide | 137 | $220,538 |
| FarxigaDapagliflozin Propanediol | 126 | $141,558 |
| AfrezzaInsulin Regular, Human | 42 | $131,652 |
| Tresiba Flextouch U-100Insulin Degludec | 60 | $47,513 |
| ProliaDenosumab | 26 | $45,075 |
| Repatha SureclickEvolocumab | 32 | $31,084 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 16 | $30,883 |
| HumalogInsulin Lispro | 98 | $30,214 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $30,047 |
| V-Go 30Sub-Q Insulin Device, 30 Unit | 58 | $29,048 |
| V-Go 20Sub-Q Insulin Device, 20 Unit | 40 | $28,421 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Baqsimi, Insulin Lispro | $1,995 | $806,719700 claims |
| Novo NordiskOzempic, Fiasp, Novolog | $3,157 | $635,922463 claims |
| Corcept TherapeuticsKorlym | $1,424 | $484,07912 claims |
| Boehringer IngelheimJardiance, Tradjenta | $1,079 | $292,673202 claims |
| AstraZenecaFarxiga | $1,276 | $141,558126 claims |
| Mannkind CorporationAfrezza | $1,443 | $131,65242 claims |
| AmgenProlia | $1,060 | $45,07526 claims |
| MerckJanuvia, Janumet Xr | $57 | $31,27834 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $28 | $24,52116 claims |
| Cequr CorporationCequr Simplicity | $741 | $9,96023 claims |
| AbbVieSynthroid | $282 | $5,59770 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Annette GantzSan Antonio$31K
- Renee ChisumSan Antonio$28K
- Thimios PartalasSan Antonio$27K
- David WeirDallas$959K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.